SEC Filings

Filing date	Form	Description	View
02/22/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-003075.pdf 0001415889-23-003075.rtf 0001415889-23-003075.xls
02/22/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-003071.pdf 0001415889-23-003071.rtf 0001415889-23-003071.xls
02/14/23	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001013594-23-000205.pdf 0001013594-23-000205.rtf 0001013594-23-000205.xls
02/14/23	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000947871-23-000189.pdf 0000947871-23-000189.rtf 0000947871-23-000189.xls
02/13/23	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001567619-23-002555.pdf 0001567619-23-002555.rtf 0001567619-23-002555.xls
02/10/23	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001357550-23-000060.pdf 0001357550-23-000060.rtf
02/10/23	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001306550-23-008612.pdf 0001306550-23-008612.rtf
02/09/23	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001104659-23-017096.pdf 0001104659-23-017096.rtf
01/30/23	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0000312069-23-000034.pdf 0000312069-23-000034.rtf
01/10/23	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001415889-23-000749.pdf 0001415889-23-000749.rtf 0001415889-23-000749.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.

Shareholder Tools